Director Safety Physician
BioNTech
Summary
The Medical Safety Physician (MSP) plays a vital role in supporting the oncology therapeutic area by providing medical safety expertise to one or more study management teams. In collaboration with assigned Safety Scientists, the MSP ensures patient safety throughout the clinical trial process. Responsibilities include contributing to clinical trial protocols, training investigators, assessing safety data (e.g., adverse events of special interest and serious adverse events), determining necessary follow-up actions, and conducting safety signal detection and evaluation. The MSP also ensures compliance with Good Clinical Practice (GCP) and regulatory reporting requirements, while contributing to essential safety documents such as Development Safety Update Reports (DSURs), updates to reference safety information, Investigator Brochures, and Clinical Trial Reports. This position offers the opportunity to take on a strategic role within the Medical Safety Pharmacovigilance (MSPv) department.
Job description
About the role
The Medical Safety Physician (MSP) plays a vital role in supporting the oncology therapeutic area by providing medical safety expertise to one or more study management teams. In collaboration with assigned Safety Scientists, the MSP ensures patient safety throughout the clinical trial process. Responsibilities include contributing to clinical trial protocols, training investigators, assessing safety data (e.g., adverse events of special interest and serious adverse events), determining necessary follow-up actions, and conducting safety signal detection and evaluation. The MSP also ensures compliance with Good Clinical Practice (GCP) and regulatory reporting requirements, while contributing to essential safety documents such as Development Safety Update Reports (DSURs), updates to reference safety information, Investigator Brochures, and Clinical Trial Reports. This position offers the opportunity to take on a strategic role within the Medical Safety Pharmacovigilance (MSPv) department.
Your Contribution
- Accountable for the quality performance of one or more safety management team(s) (SMTs)
- Oversees safety monitoring, signal management, and the benefit-risk of assigned products through the product life cycle
- Identifies and leads escalation, management, and communication of safety inquiries and concerns for assigned products
- Formulates and drives the optimal safety strategy for assigned oncology programs in clinical development at the portfolio level
- Presents and interacts with Regulatory Authorities on safety matters
- Oversees quality content of the safety contributions to clinical and regulatory documents such as briefing book for regulatory authority meetings, investigator’s brochure, clinical study report safety conclusion section, responses to regulatory authority inquiries, and other clinical/regulatory documents as needed
- Participates in due diligence for BioNTech’s Licensing /Acquisition initiatives
- Represents MSPv in Alliance management projects such as safety data exchange agreement negotiations; or joint oversight committees with development partners, and/or other collaborative development projects
- Serves as safety subject matter expert at the portfolio level and is the arbiter for safety-related issues in any of its constituting programs
- Ensures activities are performed in compliance with applicable law, global and local regulations, and in accordance with internal and external quality standards
- Trains and mentors Safety Physicians and Safety Scientists
A good match
- Medical Degree (or internationally recognized equivalent). A MD/PhD and/or certified training in a relevant medical discipline is a plus.
- Extensive drug safety/pharmacovigilance experience within the biopharmaceutical/biotechnology industry that includes the development of innovative drugs, BLA/MAA submissions, and advisory committee experience, preferably in immuno-oncology/inflammation therapeutic area(s)
- Exposure to, or direct experience in working with Regulatory Agencies on development strategies for innovative oncology products, particularly those of US
- Has achieved demonstrable results in a matrix organization and in a multidisciplinary team, experience in implementing GCP standards in clinical trials, in particular safety reporting in compliance with global and local regulations
Requirements
- Medical Degree (or internationally recognized equivalent)
- Extensive drug safety/pharmacovigilance experience within the biopharmaceutical/biotechnology industry
- Experience with development of innovative drugs, BLA/MAA submissions, and advisory committee experience
- Exposure to or direct experience working with Regulatory Agencies on development strategies for innovative oncology products, particularly US
- Demonstrable results in a matrix organization and in a multidisciplinary team
- Experience implementing GCP standards in clinical trials, particularly safety reporting in compliance with global and local regulations
Benefits
- Competitive remuneration packages
Company overview
BioNTech SE is a pioneering German multinational biotechnology company headquartered in Mainz, Germany, that specializes in developing innovative immunotherapies and vaccines for cancer and infectious diseases. Founded in 2008 by scientists Uğur Şahin, Özlem Türeci, and Christoph Huber, the company gained global recognition for co-developing the first approved mRNA-based COVID-19 vaccine with Pfizer. BioNTech's core expertise lies in mRNA technology, which it has been researching for over 15 years, with applications spanning individualized cancer medicine, infectious disease prevention, and novel therapeutic approaches. The company operates a diversified portfolio including mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies, and antibody-drug conjugates. With approximately 6,800 employees across more than 20 global sites, BioNTech maintains a strong focus on oncology, advancing multiple late-stage clinical programs while expanding its infectious disease pipeline to address conditions like malaria, tuberculosis, and mpox. The company's strategic acquisitions, including InstaDeep for AI capabilities and CureVac for mRNA expertise, further strengthen its position as a leader in next-generation biopharmaceutical innovation.